These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 31981493
1. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy. Wasala NB, Yue Y, Lostal W, Wasala LP, Niranjan N, Hajjar RJ, Babu GJ, Duan D. Mol Ther; 2020 Mar 04; 28(3):845-854. PubMed ID: 31981493 [Abstract] [Full Text] [Related]
4. Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy. Wasala NB, Yue Y, Vance J, Duan D. J Mol Cell Cardiol; 2017 Jan 04; 102():45-52. PubMed ID: 27908661 [Abstract] [Full Text] [Related]
5. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. Bostick B, Shin JH, Yue Y, Wasala NB, Lai Y, Duan D. J Mol Cell Cardiol; 2012 Aug 04; 53(2):217-22. PubMed ID: 22587991 [Abstract] [Full Text] [Related]
6. Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model. Wasala NB, Yue Y, Hu B, Shin JH, Srivastava A, Yao G, Duan D. Hum Gene Ther; 2023 May 04; 34(9-10):449-458. PubMed ID: 36515166 [Abstract] [Full Text] [Related]
7. Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice. Nogami K, Maruyama Y, Sakai-Takemura F, Motohashi N, Elhussieny A, Imamura M, Miyashita S, Ogawa M, Noguchi S, Tamura Y, Kira JI, Aoki Y, Takeda S, Miyagoe-Suzuki Y. Hum Mol Genet; 2021 May 31; 30(11):1006-1019. PubMed ID: 33822956 [Abstract] [Full Text] [Related]
8. Transcriptional changes of genes encoding sarcoplasmic reticulum calcium binding and up-taking proteins in normal and Duchenne muscular dystrophy dogs. Morales ED, Wang D, Burke MJ, Han J, Devine DD, Zhang K, Duan D. BMC Musculoskelet Disord; 2024 Oct 14; 25(1):811. PubMed ID: 39402529 [Abstract] [Full Text] [Related]
9. SERCA2a overexpression improves muscle function in a canine Duchenne muscular dystrophy model. Kodippili K, Hakim CH, Burke MJ, Yue Y, Teixeira JA, Zhang K, Yao G, Babu GJ, Herzog RW, Duan D. Mol Ther Methods Clin Dev; 2024 Jun 13; 32(2):101268. PubMed ID: 38911286 [Abstract] [Full Text] [Related]
10. Intracellular calcium handling in ventricular myocytes from mdx mice. Williams IA, Allen DG. Am J Physiol Heart Circ Physiol; 2007 Feb 13; 292(2):H846-55. PubMed ID: 17012353 [Abstract] [Full Text] [Related]
11. Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice. Xu L, Lau YS, Gao Y, Li H, Han R. Mol Ther; 2019 Aug 07; 27(8):1407-1414. PubMed ID: 31129119 [Abstract] [Full Text] [Related]
12. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Zhang Y, Yue Y, Li L, Hakim CH, Zhang K, Thomas GD, Duan D. Hum Mol Genet; 2013 Sep 15; 22(18):3720-9. PubMed ID: 23681067 [Abstract] [Full Text] [Related]
13. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Voit A, Patel V, Pachon R, Shah V, Bakhutma M, Kohlbrenner E, McArdle JJ, Dell'Italia LJ, Mendell JR, Xie LH, Hajjar RJ, Duan D, Fraidenraich D, Babu GJ. Nat Commun; 2017 Oct 20; 8(1):1068. PubMed ID: 29051551 [Abstract] [Full Text] [Related]
14. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition. Tanihata J, Nagata T, Ito N, Saito T, Nakamura A, Minamisawa S, Aoki Y, Ruegg UT, Takeda S. Biochem Biophys Res Commun; 2018 Oct 20; 505(1):51-59. PubMed ID: 30236982 [Abstract] [Full Text] [Related]
15. Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Bostick B, Yue Y, Lai Y, Long C, Li D, Duan D. Hum Gene Ther; 2008 Aug 20; 19(8):851-6. PubMed ID: 18666839 [Abstract] [Full Text] [Related]
16. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice. Mareedu S, Pachon R, Thilagavathi J, Fefelova N, Balakrishnan R, Niranjan N, Xie LH, Babu GJ. Am J Physiol Heart Circ Physiol; 2021 Jan 01; 320(1):H200-H210. PubMed ID: 33216625 [Abstract] [Full Text] [Related]
17. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Circulation; 2003 Sep 30; 108(13):1626-32. PubMed ID: 12952841 [Abstract] [Full Text] [Related]
18. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models. Hakim CH, Kumar SRP, Pérez-López DO, Wasala NB, Zhang D, Yue Y, Teixeira J, Pan X, Zhang K, Million ED, Nelson CE, Metzger S, Han J, Louderman JA, Schmidt F, Feng F, Grimm D, Smith BF, Yao G, Yang NN, Gersbach CA, Chen SJ, Herzog RW, Duan D. Nat Commun; 2021 Nov 24; 12(1):6769. PubMed ID: 34819506 [Abstract] [Full Text] [Related]
19. [Gene therapy for muscular dystrophy]. Takeda S. No To Hattatsu; 2004 Mar 24; 36(2):117-23. PubMed ID: 15031985 [Abstract] [Full Text] [Related]
20. Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy. Paran CW, Zou K, Ferrara PJ, Song H, Turk J, Funai K. Biochim Biophys Acta; 2015 Dec 24; 1851(12):1530-8. PubMed ID: 26361872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]